MĆ³nica L Fanarraga | Nanobiotechnology | Excellence in Research

Posted on by ScienceFather

Prof Dr. MĆ³nica L Fanarraga | Nanobiotechnology | Excellence in Research

Prof Dr. MĆ³nica L Fanarraga, Universidad de Catabria, Spain

šŸ‘©ā€šŸ”¬ Prof. Dr. MĆ³nica L. FanarragašŸŽ“ An esteemed researcher and Professor at the University of Cantabria, Spain, Dr. MĆ³nica L. Fanarraga is a trailblazer in nanomedicine. With dual PhDs in Biology and Medicine/Surgery, she founded the “Nanomedicine” research group at IDIVAL Institute. Over 40 competitive projects and 70 JCR publications showcase her impact. Recognized with the “Best Researcher Award” in 2022, she mentors researchers and champions innovation. Dr. Fanarraga’s recent projects secured substantial funding, affirming her dedication to cutting-edge nanomedicine research. Her contributions extend to patents, including groundbreaking work on silica nanoparticles, emphasizing her commitment to advancing scientific knowledge for over 30 years. šŸŒšŸ”¬šŸ†

šŸ« Education & Experience:

šŸŽ“ Degrees in Veterinary Medicine (1989). šŸ“š Dual PhDs in Biology (1993) and Medicine and Surgery (1999). šŸ§Ŗ Founder of the “Nanomedicine” research group at IDIVAL Institute, Santander, Spain. šŸ‘©ā€šŸ« Current Professor at the University of Cantabria. šŸ† “Best Researcher Award” from Fenin (Spanish Platform for Innovation in Health Technology, 2022).

šŸ”¬ Academic Achievements:

šŸŒ Spearheaded over 40 competitive research projects in nanobiotechnology. šŸ“š Published 70+ JCR publications in esteemed journals. šŸ“ Principal Investigator for articles in journals like Adv. Healthc. Mat., J.Nanobiotech, Angewandte Chem, Nature, ACS Nano. šŸ… Secured 5 patents in the field of nanomedicine. šŸŽ“ Mentored 10 postdoctoral researchers and supervised 14 defended doctoral theses. šŸ… 6 theses received the “Extraordinary Prize,” 2 awarded the “Juan MĀŖ ParĆ©s” Prize.

šŸ’” Contributions to Research & Development:

šŸŒŸ Led successful projects, including TED2021-129248B-I00, securing ā‚¬426,650 in funding. šŸ’° Secured funding for various Innovation projects, ranging from ā‚¬15,000 to ā‚¬56,100. šŸŒ Actively involved in mentoring young scientists for national and international postdoctoral initiatives. šŸ† Key role in Marie Curie H2020-MSCA-IF-2019 project (ā‚¬62,220) and Horizon-MSCA-Doctoral Networks 2021 project (ā‚¬250,000).

šŸ§Ŗ Innovations in Nanomedicine:

šŸ§¬ Pioneering work on silica nanoparticles for nucleic acid encapsulation (2021). šŸ”„ Innovative approaches in protein (2017) and carbon nanotube conjugation of nanomaterials (2017). šŸ§  Contributions to neurodegenerative disease research and advancements in gene transfer methods showcase continuous efforts in pushing scientific boundaries over 30 years.

Professional Profiles:

The impact of her research is evident in citation metrics and indices from Google Scholar:

  • Cited by: All ā€“ 2906.
  • Citations ā€“ 2906.
  • h-index ā€“ 29.
  • Documents ā€“ 100.

A prolific researcher making meaningful contributions to the academic world!

šŸ”¬ Research Focus:

šŸ” Prof Dr. Fanarraga has made significant contributions in the fields of cell biology and nanomedicine. Her pioneering work encompasses critical areas such as organelle transport, microtubule dynamics, and controlled drug delivery systems. With a remarkable citation record, her impactful studies on dynactin’s role in bidirectional organelle transport (399 citations) and the uncoupling of hypomyelination and glial cell death (238 citations) showcase her expertise in cell biology. Additionally, her exploration of postchaperonin tubulin folding cofactors (163 citations) and their role in microtubule dynamics demonstrates a multifaceted approach to understanding cellular processes. Dr. Fanarraga’s diversified research extends to innovative applications, including magnetic hyperthermia-enhanced cell toxicity (125 citations) and the use of carbon nanotubes in mimicking microtubule properties (81 citations). Her extensive body of work reflects a commitment to advancing knowledge at the intersection of cellular biology and nanomedicine. šŸŒšŸ”¬

Publications Top Note: